11-118372686-C-G
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The ENST00000431736.6(UBE4A):āc.741C>Gā(p.Ile247Met) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000269 in 1,608,402 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
ENST00000431736.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE4A | NM_001204077.2 | c.721+20C>G | intron_variant | ENST00000252108.8 | NP_001191006.1 | |||
UBE4A | NM_004788.4 | c.741C>G | p.Ile247Met | missense_variant, splice_region_variant | 6/20 | NP_004779.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE4A | ENST00000431736.6 | c.741C>G | p.Ile247Met | missense_variant, splice_region_variant | 6/20 | 1 | ENSP00000387362 | |||
UBE4A | ENST00000252108.8 | c.721+20C>G | intron_variant | 1 | NM_001204077.2 | ENSP00000252108 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000493 AC: 75AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00108 AC: 264AN: 245062Hom.: 3 AF XY: 0.00106 AC XY: 140AN XY: 132638
GnomAD4 exome AF: 0.000248 AC: 361AN: 1456110Hom.: 5 Cov.: 31 AF XY: 0.000254 AC XY: 184AN XY: 724480
GnomAD4 genome AF: 0.000473 AC: 72AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.000524 AC XY: 39AN XY: 74464
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at